All human beings are 99.9 percent identical in their genetic makeup. Differences in the remaining 0.1 percent hold important clues about the causes of diseases, including cancer. At CCR, innovative genome-based and bioinformatics approaches are being applied to identify the molecular targets that are uniquely expressed in cancers; these targets are then used to develop new prevention, detection, diagnosis and treatment options for cancer patients and their physicians. This research is critical for realizing the benefits of personalized medicine, addressing health disparities and improving global health. We invite you to meet some of our principal investigators conducting research in this area.